(34 days)
The Glucose Meter-Check Control Solution for AgaMatrix is intended for use to verify the performance and correct operation of the AgaMatrix blood glucose monitoring test systems utilizing the WaveSense family of blood glucose test strips. Glucose Meter-Check Control Solution for AgaMatrix is intended for use by healthcare professionals and people with diabetes mellitus at home.
Glucose Meter-Check Control Solution for AgaMatrix is a buffered aqueous solution with glucose containing no ingredients of biological origin, or in concentrations qualifying as a controlled product under the Controlled Products Regulation. The Glucose Meter-Check Control Solution is formulated for optimal performance on AgaMatrix glucose meters utilizing the WaveSense family of test strips.
The provided text describes a 510(k) summary for the Glucose Meter-Check Control Solution for AgaMatrix. It details the device's characteristics, intended use, and comparison to a predicate device for substantial equivalence. However, it does not contain detailed information about specific acceptance criteria or the results of a study designed to prove the device meets these criteria.
The document mentions "Tests were conducted to verify specific performance requirements" in section (b)(1) within part {1}, listing categories like "Closed bottle stability (Shelf-life)," "Stability after opening (Use-life)," "Transport Stability," and "Test response." However, it does not provide the actual acceptance criteria for these tests or the reported performance data from these tests.
Therefore, I cannot populate the table or answer most of the specific questions as the required information is not present in the provided text.
Here is a summary of what can be extracted and what is missing:
1. Table of Acceptance Criteria and Reported Device Performance
Not available in the provided text. The document states that tests were conducted for stability and test response, but it does not specify the acceptance criteria (e.g., "glucose concentration should be within X% of target") or the actual results obtained from these tests.
2. Sample size used for the test set and the data provenance
Not available in the provided text. There is no mention of sample sizes or data provenance (country of origin, retrospective/prospective) for any testing.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable/available. This device is a control solution for glucose meters, not an AI/diagnostic imaging device requiring expert ground truth for interpretation of complex data. The "ground truth" for a control solution would typically be its known glucose concentration, established through a traceable analytical method rather than expert consensus on images or clinical cases.
4. Adjudication method for the test set
Not applicable/available. Adjudication methods like 2+1 or 3+1 are typically used for expert consensus in diagnostic imaging studies. This is not relevant for a glucose control solution.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This device is a control solution for glucose meters, not an AI-assisted diagnostic tool. Therefore, MRMC studies and AI effect sizes are not relevant.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This device is a control solution, not an algorithm.
7. The type of ground truth used
For a control solution, the ground truth would be the known, analytically determined concentration of glucose within the solution. While the document doesn't explicitly state "analytically determined glucose concentration was used as ground truth," this is the standard for such products.
8. The sample size for the training set
Not applicable. This is a control solution, not a machine learning model, so there is no "training set."
9. How the ground truth for the training set was established
Not applicable. As there is no training set.
§ 862.1660 Quality control material (assayed and unassayed).
(a)
Identification. A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.(b)
Classification. Class I (general controls). Except when intended for use in donor screening tests, quality control materials (assayed and unassayed) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.